InMode (INMD) rose 14% after a report that a foreign investment fund is in talks to purchase the Israeli medical aesthetics ...

A foreign investment fund could scoop up medical aesthetics outlet InMode for $1.1 billion, an analyst said Monday as InMode ...

InMode is rumored to be in advanced deal talks with a foreign investment fund, Calcalist, an Israeli newspaper reported this week. According to the report, the medical aesthetic device company could ...

It is hard to get excited after looking at InMode's (NASDAQ:INMD) recent performance, when its stock has declined ...

Wall Street expects a year-over-year increase in earnings on higher revenues when InMode (INMD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...